| P50 | author | Domenico D'Amico | Q51846705 |
| | Matilde Leonardi | Q56936660 |
| | Ambra Mara Giovannetti | Q59661034 |
| | Carla Sabariego | Q60463513 |
| | Rui Quintas | Q63409961 |
| | Alarcos Cieza | Q86034688 |
| | Alberto Raggi | Q37830338 |
| P2093 | author name string | Jerome Edmound Bickenbach | |
| P2860 | cites work | Prevalence of headache in Europe: a review for the Eurolight project | Q24595087 |
| | The impact of an over-the-counter migraine medication program on quality of life | Q28195052 |
| | Association between lifestyle factors and headache | Q28741307 |
| | The International Classification of Headache Disorders: 2nd edition | Q29547231 |
| | Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data | Q33438961 |
| | Comprehensive surgical treatment of migraine headaches | Q33984070 |
| | SF-36 health survey update | Q34109918 |
| | Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial | Q34167309 |
| | Biofeedback-assisted relaxation in migraine headache: relationship to cerebral blood flow velocity in the middle cerebral artery | Q34179553 |
| | Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs | Q34606909 |
| | The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 |
| | Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial | Q34628169 |
| | Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients | Q34655095 |
| | Migraine and psychiatric comorbidity: a review of clinical findings | Q34770834 |
| | Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study | Q34771096 |
| | Transcatheter interatrial shunt closure as a cure for migraine: can it be justified by paradoxical embolism-risk-driven criteria? | Q34966164 |
| | A placebo-controlled surgical trial of the treatment of migraine headaches | Q34994892 |
| | Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study | Q35113455 |
| | The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials | Q36168171 |
| | Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms | Q36248681 |
| | Effect of preventive treatment on health-related quality of life in episodic migraine | Q36260569 |
| | The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). | Q36261290 |
| | Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life | Q36356554 |
| | The cycle of migraine: patients' quality of life during and between migraine attacks | Q36909877 |
| | Prophylaxis of migraine: general principles and patient acceptance | Q37106958 |
| | Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk | Q37546078 |
| | Work and productivity loss in the rizatriptan multiple attack study. | Q50507084 |
| | Comparison of Short Form-36 and Migraine Disability Assessment questionnaire in patients with migraine. | Q51799105 |
| | Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. | Q51808225 |
| | A self-administered behavioral intervention using tailored messages for migraine. | Q51839629 |
| | Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. | Q51903671 |
| | Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. | Q51948254 |
| | Migraine, quality of life, and depression: a population-based case-control study. | Q51974169 |
| | A study to evaluate the feasibility of an aerobic exercise program in patients with migraine. | Q53131208 |
| | ICF linking rules: an update based on lessons learned. | Q53270373 |
| | Disability and quality of life in different primary headaches: results from Italian studies | Q62692873 |
| | Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society | Q70213757 |
| | An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score | Q73016930 |
| | The family impact of migraine: population-based studies in the USA and UK | Q73527905 |
| | Assessing the ability of topiramate to improve the daily activities of patients with migraine | Q79228488 |
| | Lay trainers with migraine for a home-based behavioral training: a 6-month follow-up study | Q82715378 |
| | Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study | Q83314884 |
| | Adherence to acute migraine medication: what does it mean, why does it matter? | Q37611984 |
| | Deep brain stimulation of the posteromedial hypothalamus: indications, long-term results, and neurophysiological considerations | Q37776699 |
| | Migraine and depression: common pathogenetic and therapeutic ground? | Q37870787 |
| | Psychosocial factors of relevance to sex and gender studies in headache | Q37883453 |
| | The cost of headache disorders in Europe: the Eurolight project | Q37963926 |
| | Psychosocial features of depression: a systematic literature review. | Q37972426 |
| | Drug-resistant chronic migraine: the Italian GON project | Q38014283 |
| | Adherence with migraine prophylaxis in clinical practice | Q38434618 |
| | Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes | Q39335482 |
| | The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache | Q39390568 |
| | Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study | Q39391112 |
| | Determinants of migraine-specific quality of life | Q39402029 |
| | Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. | Q42327504 |
| | Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study | Q42632012 |
| | Patient preference for triptan formulations: a prospective study with zolmitriptan | Q42632079 |
| | Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study | Q43586102 |
| | Effects of medication use on health state in postictal migraineurs | Q43750255 |
| | Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine | Q43795307 |
| | Health-related quality of life measures and psychiatric comorbidity in patients with migraine | Q43885692 |
| | Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study. | Q43912873 |
| | Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks | Q44161144 |
| | Reduced impact of migraine in everyday life: an observational study in the Dutch Society of Headache Patients | Q44465537 |
| | Stress, anxiety, depression and migraine | Q44786193 |
| | Measure of negative impact of migraine on daily activities, social relationships and therapeutic approach | Q45154044 |
| | The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. | Q45174895 |
| | Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study | Q46572337 |
| | Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study | Q46657577 |
| | Topiramate improves health-related quality of life when used to prevent migraine | Q46657587 |
| | Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial | Q46731911 |
| | Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study. | Q46761733 |
| | Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? | Q46816143 |
| | Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues | Q46875283 |
| | SMILE: first observational prospective cohort study of migraine in primary care in France. Description of methods and study population. | Q46881705 |
| | Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial | Q46910225 |
| | A case-control study on excessive daytime sleepiness in episodic migraine | Q48458772 |
| | A randomized, controlled trial of massage therapy as a treatment for migraine | Q48495557 |
| | Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. | Q48559164 |
| | Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial | Q48572094 |
| | Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center | Q48779169 |
| | Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study | Q48960051 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P921 | main subject | mental disorder | Q12135 |
| | migraine | Q133823 |
| | systematic review | Q1504425 |
| | social behavior disorders | Q69990409 |
| P304 | page(s) | 595-606 | |
| P577 | publication date | 2012-09-23 | |
| | 2012-11-01 | |
| P1433 | published in | The journal of headache and pain : official journal of the Italian Society for the Study of Headaches | Q26842211 |
| P1476 | title | A systematic review of the psychosocial difficulties relevant to patients with migraine | |
| P478 | volume | 13 | |